COVID 19: Respiratory Management by Non Invasive Ventilation

dc.contributor.authorShah, Men_US
dc.contributor.authorModi, Uen_US
dc.contributor.authorGajjar, Men_US
dc.contributor.authorKalsaria, Ken_US
dc.contributor.authorPathak, Sen_US
dc.contributor.authorJarwani, B.en_US
dc.date.accessioned2023-07-14T08:15:47Z
dc.date.available2023-07-14T08:15:47Z
dc.date.issued2021-10
dc.description.abstractBackground:During this long COVID-19 pandemic outbreak, continuous positive airway pressure (CPAP) and noninvasive ventilation (NIV) are being widely used to treat of NIV in COVID-19 acute respiratory distress syndrome (ARDS) are lacking, and for this reason it is extremely important to accurately determine the outcomes of this strategy. This study aimed to evaluate clinical data and outcomes of NIV in patients with COVID-19 ARDS.Material And Methods:This is retrospective observation study conducted at government hospital during April 2020 to July 2020. The study was approved by local ethical committee.We analyzed patients with the laboratory confirmed case of COVID-19 infection admitted in intensive care unit who require positive pressure ventilation and perfusion which are not able to maintain on simple O2 masks/ nasal cannula /NRBM. Data related to clinical features and co-morbidities were recorded at admission and clinical laboratory data were recorded at start of NIV and respiratory parameter were recorded at the time of admission, start of NIV and at the time of weaning or shift to invasive ventilation.Result:Out of 119 patients 42 patients were successfully weaned off from non invasive ventilation while remaining were shifted to invasive mechanical ventilation. The patients who were shifted to invasive ventilation were all died. Low P/F ratio, high CRP, high D-dimer, high LDH and high ferritin levels were related to conversion to invasive ventilation and high mortality among the group.Conclusion:Although there is a role for non-invasive respiratory therapies in the context of COVID-19 ARF, more research is still needed to define the balance of benefits and risks to patients. Indirectly, non-invasive respiratory therapies may be of particular benefit in reducing the risks to healthcare workers by obviating the need for intubation, a potentially highly infectious procedure.en_US
dc.identifier.affiliationsResident Doctor(R3)en_US
dc.identifier.affiliationsAssistant Professoren_US
dc.identifier.affiliationsResident Doctor(R2)en_US
dc.identifier.affiliationsResident Doctor(R1)en_US
dc.identifier.affiliationsProfessor & Head Of Department, Emergency Medicine Department, Smt. NHL Municipal Medical College, SVP Hosptial,, Ellis Bridge, Paldi, Ahmedabad-380006. Gujaraten_US
dc.identifier.citationShah M, Modi U, Gajjar M, Kalsaria K, Pathak S, Jarwani B.. COVID 19: Respiratory Management by Non Invasive Ventilation . National Journal of Integrated Research in Medicine. 2021 Oct; 12(4): 01-07en_US
dc.identifier.issn0975-9840
dc.identifier.issn2230 - 9969
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/219778
dc.languageenen_US
dc.publisherAssociation of Health Professionals and Health Educatorsen_US
dc.relation.issuenumber4en_US
dc.relation.volume12en_US
dc.source.urihttps://nicpd.ac.in/ojs-/index.php/njirm/article/view/3117en_US
dc.subjectAcute Respiratory Failureen_US
dc.subjectHigh Flow Nasal Cannulaen_US
dc.subjectNoninvasive Ventilationen_US
dc.titleCOVID 19: Respiratory Management by Non Invasive Ventilationen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
NJIRM2021v12n4p1.pdf
Size:
1005.85 KB
Format:
Adobe Portable Document Format